EDAP TMS S.A Return on Tangible Equity 2010-2025 | EDAP
Current and historical return on tangible equity values for EDAP TMS S.A (EDAP) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| EDAP TMS S.A Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-03-31 | $-0.02B | $0.04B | -54.76% |
| 2024-12-31 | $-0.02B | $0.04B | -44.68% |
| 2024-09-30 | $-0.02B | $0.05B | -46.15% |
| 2024-06-30 | $-0.02B | $0.05B | -37.50% |
| 2024-03-31 | $-0.02B | $0.06B | -31.40% |
| 2023-12-31 | $-0.02B | $0.06B | -34.24% |
| 2023-09-30 | $-0.02B | $0.06B | -32.47% |
| 2023-06-30 | $-0.02B | $0.07B | -25.71% |
| 2023-03-31 | $-0.01B | $0.07B | -16.54% |
| 2022-12-31 | $0.00B | $0.07B | -4.80% |
| 2022-09-30 | $0.00B | $0.07B | 6.96% |
| 2022-06-30 | $0.00B | $0.05B | 5.63% |
| 2022-03-31 | $0.00B | $0.05B | 0.00% |
| 2021-12-31 | $0.00B | $0.05B | 2.11% |
| 2021-09-30 | $0.00B | $0.05B | 0.00% |
| 2021-06-30 | $0.00B | $0.05B | 0.00% |
| 2021-03-31 | $0.00B | $0.03B | 4.71% |
| 2020-12-31 | $0.00B | $0.03B | -7.14% |
| 2020-09-30 | $0.00B | $0.03B | -22.22% |
| 2020-06-30 | $0.00B | -14.81% | |
| 2020-03-31 | $0.00B | -14.81% | |
| 2019-12-31 | $0.00B | $0.03B | 7.55% |
| 2019-09-30 | $0.00B | 15.38% | |
| 2019-03-31 | $0.00B | -7.69% | |
| 2018-12-31 | $0.00B | $0.03B | -7.69% |
| 2018-09-30 | $0.00B | -15.69% | |
| 2018-06-30 | $0.00B | $0.03B | -15.69% |
| 2018-03-31 | $0.00B | -24.00% | |
| 2017-12-31 | $0.00B | $0.03B | -8.00% |
| 2017-09-30 | $0.00B | -16.33% | |
| 2017-06-30 | $0.00B | $0.03B | 0.00% |
| 2017-03-31 | $0.01B | 40.82% | |
| 2016-12-31 | $0.01B | $0.02B | 40.82% |
| 2016-09-30 | $0.01B | 126.32% | |
| 2016-06-30 | $0.01B | $0.03B | 63.16% |
| 2016-03-31 | $0.00B | 64.00% | |
| 2015-12-31 | $0.00B | $0.01B | -16.00% |
| 2015-09-30 | $-0.01B | -137.93% | |
| 2015-06-30 | $0.00B | $0.01B | 55.17% |
| 2015-03-31 | $0.00B | -55.17% | |
| 2014-12-31 | $0.00B | $0.02B | 0.00% |
| 2014-09-30 | $0.00B | 38.10% | |
| 2014-06-30 | $-0.01B | $0.01B | -133.33% |
| 2014-03-31 | $0.00B | 0.00% | |
| 2013-12-31 | $-0.01B | $0.01B | -75.00% |
| 2013-09-30 | $-0.01B | -80.00% | |
| 2013-06-30 | $-0.01B | $0.01B | -62.22% |
| 2013-03-31 | $-0.01B | $0.01B | -78.43% |
| 2012-12-31 | $-0.01B | $0.01B | -65.45% |
| 2012-09-30 | $-0.01B | $0.02B | -63.16% |
| 2012-06-30 | $-0.01B | $0.02B | -46.67% |
| 2012-03-31 | $-0.01B | $0.02B | -45.28% |
| 2011-12-31 | $0.00B | $0.01B | -14.29% |
| 2011-09-30 | $-0.01B | $0.02B | -78.57% |
| 2011-06-30 | $-0.01B | $0.01B | -96.55% |
| 2011-03-31 | $-0.01B | $0.02B | -88.14% |
| 2010-12-31 | $-0.02B | $0.01B | -107.94% |
| 2010-09-30 | $-0.01B | $0.02B | -29.41% |
| 2010-06-30 | $-0.01B | $0.01B | -60.27% |
| 2010-03-31 | $-0.01B | $0.02B | -55.70% |
| 2009-12-31 | $-0.01B | $0.01B | -53.66% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.057B | $0.069B |
| EDAP TMS S.A. develops, produces, markets and distributes minimally invasive medical devices, primarily for the treatment of urological diseases. They currently produce and market devices for treatment of benign prostate hyperplasia and urinary tract stones. They are also developing a third range of products for minimally invasive destruction of certain types of tumors. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $183.532B | 80.39 |
| Thermo Fisher Scientific (TMO) | United States | $164.157B | 19.86 |
| Edwards Lifesciences (EW) | United States | $45.784B | 30.02 |
| Alcon (ALC) | Switzerland | $43.149B | 29.16 |
| IDEXX Laboratories (IDXX) | United States | $42.895B | 49.29 |
| DexCom (DXCM) | United States | $32.690B | 50.53 |
| IQVIA Holdings (IQV) | United States | $28.164B | 15.78 |
| Mettler-Toledo (MTD) | United States | $25.437B | 30.25 |
| STERIS (STE) | Ireland | $22.432B | 24.71 |
| Waters (WAT) | United States | $21.001B | 29.63 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.363B | 0.00 |
| Hologic (HOLX) | United States | $14.645B | 15.91 |
| Sysmex ADR (SSMXY) | Japan | $10.626B | 30.14 |
| Penumbra (PEN) | United States | $9.214B | 72.32 |
| Masimo (MASI) | United States | $8.837B | 32.60 |
| Globus Medical (GMED) | United States | $7.733B | 18.43 |
| Glaukos (GKOS) | United States | $5.932B | 0.00 |
| Teleflex (TFX) | United States | $5.144B | 8.49 |
| Integer Holdings (ITGR) | United States | $4.186B | 21.93 |
| TransMedics (TMDX) | United States | $3.804B | 82.69 |
| PROCEPT BioRobotics (PRCT) | United States | $3.134B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.417B | 14.39 |
| Veracyte (VCYT) | United States | $2.121B | 29.76 |
| Nihon Kohden (NHNKY) | Japan | $1.942B | 22.27 |
| Elekta AB (EKTAY) | Sweden | $1.903B | 17.10 |
| Alphatec Holdings (ATEC) | United States | $1.606B | 0.00 |
| Artivion (AORT) | United States | $1.343B | 125.84 |
| Pulse Biosciences (PLSE) | United States | $1.078B | 0.00 |
| OPKO Health (OPK) | United States | $1.071B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.038B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.978B | 5.20 |
| SiBone (SIBN) | United States | $0.733B | 0.00 |
| IRadimed (IRMD) | United States | $0.732B | 37.14 |
| Semler Scientific (SMLR) | United States | $0.623B | 13.51 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.552B | 8.58 |
| Beta Bionics (BBNX) | United States | $0.549B | 0.00 |
| AxoGen (AXGN) | United States | $0.542B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.532B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.471B | 11.05 |
| Pacific Biosciences Of California (PACB) | United States | $0.441B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.433B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.395B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.378B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.377B | 0.00 |
| RxSight (RXST) | United States | $0.325B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.319B | 0.00 |
| NeuroPace (NPCE) | United States | $0.312B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.260B | 0.00 |
| 908 Devices (MASS) | United States | $0.249B | 0.00 |
| Neuronetics (STIM) | United States | $0.236B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.232B | 14.03 |
| Inogen (INGN) | United States | $0.186B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.178B | 0.00 |
| CVRx (CVRX) | United States | $0.178B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.176B | 0.00 |
| LENSAR (LNSR) | United States | $0.154B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.147B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.143B | 0.00 |
| Accuray (ARAY) | United States | $0.140B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.123B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.121B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.117B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.115B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.095B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.073B | 0.00 |
| Spectral AI (MDAI) | United States | $0.072B | 0.00 |
| InspireMD (NSPR) | United States | $0.072B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.068B | 41.60 |
| Hyperfine (HYPR) | United States | $0.060B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.056B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.054B | 21.96 |
| Vicarious Surgical (RBOT) | United States | $0.048B | 0.00 |
| Precision Optics (POCI) | United States | $0.038B | 0.00 |
| Envoy Medical (COCH) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.032B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.026B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.022B | 0.00 | |
| NexGel (NXGL) | United States | $0.021B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.015B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.006B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.45 |